Literature DB >> 30066367

Renal tumors in end-stage renal disease: A comprehensive review.

Toyonori Tsuzuki1, Hidehiro Iwata1,2, Yota Murase1,2, Taishi Takahara1, Akiko Ohashi1.   

Abstract

The incidence of end-stage renal disease has increased owing to the greater prevalence of patients with chronic kidney disease and diabetes mellitus. End-stage renal disease is usually accompanied by acquired cystic disease and is a risk factor for renal cell carcinoma. The present review discusses the etiology of renal cell carcinoma in end-stage renal disease patients, focusing on two unique renal cell carcinoma histological subtypes: acquired cystic disease-associated renal cell carcinoma and clear cell papillary renal cell carcinoma. Acquired cystic disease-associated renal cell carcinoma occurs almost exclusively in patients who underwent hemodialysis, especially long-term (>10 years) hemodialysis. Its histology is distinctive: a cribriform or sieve-like architecture with intra- or intracystic lumina; tumor cells containing abundant eosinophilic cytoplasm and large nuclei with prominent nucleoli; and most notably, calcium oxalate crystal deposition. Recognition of the crystals is critical for diagnosing acquired cystic disease-associated renal cell carcinoma. Acquired cystic disease-associated renal cell carcinoma typically has an indolent clinical course, except in cases with sarcomatoid components. Clear cell papillary renal cell carcinoma also has an indolent course (no cases involving metastasis have been reported to date), and its features resemble those of both clear cell renal cell carcinoma and papillary renal cell carcinoma. Unlike acquired cystic disease-associated renal cell carcinoma, which occurs only in end-stage renal disease patients, clear cell papillary renal cell carcinoma occurs in non-end-stage renal disease patients as well. Additional renal tumors in end-stage renal disease patients include anastomosing hemangiomas. Long-term hemodialysis worsens the prognosis of end-stage renal disease patients with renal cell carcinoma, regardless of its original histological subtype, presumably by inducing oxidative stress and sarcomatoid transformation.
© 2018 The Japanese Urological Association.

Entities:  

Keywords:  acquired cystic kidney disease; end-stage renal disease; hemodialysis; pathology; renal cell tumor

Mesh:

Year:  2018        PMID: 30066367     DOI: 10.1111/iju.13759

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  10 in total

1.  Outcome of advanced renal cell carcinoma arising in end-stage renal disease: comparison with sporadic renal cell carcinoma.

Authors:  Hiroki Ishihara; Hironori Fukuda; Hidekazu Tachibana; Kazuhiko Yoshida; Hirohito Kobayashi; Toshio Takagi; Junpei Iizuka; Hideki Ishida; Yoji Nagashima; Tsunenori Kondo; Kazunari Tanabe
Journal:  Clin Exp Nephrol       Date:  2021-02-27       Impact factor: 2.801

2.  Acquired cystic disease subtype renal cell carcinoma (ACD-RCC): prevalence and imaging features at a single institution.

Authors:  Molly B Carnahan; Jacqueline Kunzelman; Akira Kawashima; Bhavik N Patel; Christine O Menias; Ghaneh Fananapazir
Journal:  Abdom Radiol (NY)       Date:  2022-06-08

Review 3.  Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function.

Authors:  Łukasz Mielczarek; Anna Brodziak; Paweł Sobczuk; Maciej Kawecki; Agnieszka Cudnoch-Jędrzejewska; Anna M Czarnecka
Journal:  Cancer Chemother Pharmacol       Date:  2021-03-25       Impact factor: 3.333

4.  Long-Term Control of Metastatic Renal Cell Carcinoma Using Pazopanib.

Authors:  Takashi Kawahara; Tappei Takeshima; Yasuhide Miyoshi; Noboru Nakaigawa; Masahiro Yao; Mikiko Tanabe; Hiroji Uemura
Journal:  Case Rep Oncol       Date:  2019-07-16

5.  Sunitinib-associated hyperammonemic encephalopathy successfully managed with higher intensity conventional hemodialysis: A case report.

Authors:  Sabrina Haroon; Stephanie Ko; Alvin Wong; Poh-Seng Tan; Evan Lee; Titus Lau
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

6.  Diffusion Tensor Imaging Features of Watershed Segmentation Algorithm for Analysis of the Relationship between Depression and Brain Nerve Function of Patients with End-Stage Renal Disease.

Authors:  Feng Zhu; Jiao Xu; Mei Yang; Haitao Chi
Journal:  J Healthc Eng       Date:  2021-10-25       Impact factor: 2.682

7.  HLA-G Is Widely Expressed by Mast Cells in Regions of Organ Fibrosis in the Liver, Lung and Kidney.

Authors:  Nicolas Mouchet; Nicolas Vu; Bruno Turlin; Nathalie Rioux-Leclercq; Stéphane Jouneau; Michel Samson; Laurence Amiot
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

8.  The genomic landscape of pediatric renal cell carcinomas.

Authors:  Pengbo Beck; Barbara Selle; Lukas Madenach; David T W Jones; Christian Vokuhl; Apurva Gopisetty; Arash Nabbi; Ines B Brecht; Martin Ebinger; Jenny Wegert; Norbert Graf; Manfred Gessler; Stefan M Pfister; Natalie Jäger
Journal:  iScience       Date:  2022-03-26

9.  Impact of comorbid renal dysfunction in patients with hepatocellular carcinoma on long-term outcomes after curative resection.

Authors:  Yuzuru Sakamoto; Shingo Shimada; Toshiya Kamiyama; Ko Sugiyama; Yoh Asahi; Akihisa Nagatsu; Tatsuya Orimo; Tatsuhiko Kakisaka; Hirofumi Kamachi; Yoichi M Ito; Akinobu Taketomi
Journal:  World J Gastrointest Surg       Date:  2022-07-27

10.  A Retrospective Study from a Single Center in China to Develop a Nomogram to Predict One-Year Mortality in Patients with End-Stage Renal Disease Who Are Receiving Hemodialysis.

Authors:  Wubin Yao; Yan Shen; Huaxing Huang; Hongli Yang; Xingxing Fang; Lianglan Shen
Journal:  Med Sci Monit       Date:  2022-07-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.